Owlet, Inc. (OWLT) is a Lehi, Utah-based pediatric health platform that sells FDA-cleared wearable infant monitors, camera systems, and the Owlet360 subscription service. In intraday trading on November 13, 2026, the stock fell 35.71% to $2.97, down from a prior close of $4.62 — a decline of $1.65 per share. The move was clearly to the downside and erased more than a third of the company's market value in a single session. The immediate cause was verified: Owlet's third-quarter results, released before the open, included the withdrawal of full-year 2026 guidance and a voluntary safety update for the cable guard accessory sold with its cameras.
The quarter itself was not the problem. Revenue of $30.4 million slipped 4.9% from $32.0 million a year earlier but landed within 1% of consensus. Adjusted earnings of $0.11 per share far exceeded expectations for a small loss, gross margin expanded 315 basis points to 53.8%, and adjusted EBITDA reached a record $3.5 million. Subscription revenue more than doubled to $3.6 million, with paying Owlet360 subscribers up 83% year over year to over 142,000.
What broke the narrative was the accompanying safety notice. After a report that a toddler became entangled in an unsecured camera cable, Owlet began shipping a replacement enclosed cable guard system free of charge to every camera owner who requests one. Management estimated $7 million to $10 million in direct program costs — production, logistics, customer support, legal and consulting — plus $9 million to $12 million in retailer returns recorded as revenue reductions. Partial offsets include $3 million to $4 million of resellable returned inventory, $2 million to $5 million in replenishment load-in, and up to $10 million of potential insurance recovery that is not guaranteed. The issue is confined to the camera accessory and does not affect Dream Sock monitoring.
Citing the stop-sale, the returns process, and near-term demand uncertainty, Owlet pulled its full-year 2026 outlook and offered no replacement range. Management said the business had been on track to reaffirm its forecast before the safety update, but the spread of possible fourth-quarter outcomes became too wide to project responsibly. For investors, the loss of guidance is the most damaging element: it arrives in the company's most important selling quarter and leaves no company-defined benchmark against consensus estimates of roughly $122 million in full-year revenue and $34 million in the fourth quarter.
Hardware revenue fell 12% to $26.8 million, reflecting the lapping of the prior-year Dream Sight launch and aggressive competitor discounting ahead of Amazon's August 2026 FDA-clearance enforcement deadline. Owlet also revised previously issued financial statements for the first quarter of 2026 and prior periods to correct overstated stock-based compensation from employee stock purchase plan valuation errors. The revision was deemed immaterial, but it adds noise to comparisons at a moment when credibility matters.
Volume was exceptionally heavy. Roughly 99,000 shares changed hands in the first 15 minutes of the session — about half of the stock's average full-day turnover of some 188,000 shares — putting the day on pace for multiples of normal activity. The selling was purely idiosyncratic: the small-cap benchmark traded slightly lower while the retail sector ETF edged higher, and there was no comparable stress among consumer hardware or pediatric health peers.
Technically, the damage is severe. Shares opened at $2.99 and printed a low of $2.87, slicing through the prior 52-week floor near $4.03 and breaking well below the $4.20–$4.60 range that had contained trading through October and early November. The stock sits far under its September levels above $5, and the gap-down leaves a large unfilled chart void overhead.
The scale runs from 0, meaning no meaningful news and a normal move for the stock, to 100, meaning transformative news and an extreme, rare price move. Owlet earns 85 out of 100.
The verified news was substantial relative to a company of this size: guidance withdrawn outright, a product safety program with remediation and returns costs equal to more than 15% of annual revenue, and a restatement of prior periods. The price move was close to 14 times the stock's average absolute daily change of about 2.6% over the past 60 sessions, and no session in that window came close to a 35% swing — the largest was roughly 11%. Major news plus a near-unprecedented move produces the high score.
Attention now shifts to the mechanics of the safety program: how many camera owners request replacement guards, how quickly retailer returns are processed, and whether the insurance recovery materializes. Owlet ended the quarter with $31.6 million in cash and roughly $39.5 million of total liquidity, which management frames as sufficient to absorb the costs while funding product work — including the newly launched Smart Thermometer, the Owlet OnCall telehealth rollout expected in late 2026 and early 2027, and the OwletOne bundle now in testing. Analysts will look for any reinstated guidance, fourth-quarter sell-through data during the holiday period, subscription churn trends, and clarification of liability exposure. The central uncertainty is whether the fourth-quarter disruption proves a one-time event or signals lasting damage to retail relationships and demand.
Tickeron's Trending AI Robots page curates the platform's strongest-performing trading bots under current market conditions, drawn from a library of hundreds of algorithms spanning thousands of tickers. Bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, so the featured group rotates as conditions change. For investors navigating volatile single-name moves like this one, the page offers a structured way to see which automated strategies are working right now — and a sensible starting point for building a watchlist.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for OWLT turned positive on November 02, 2026. Looking at past instances where OWLT's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator entered the oversold zone -- be on the watch for OWLT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where OWLT advanced for three days, in 209 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
OWLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OWLT as a result. In 73 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OWLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for OWLT entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.847) is normal, around the industry mean (4.142). P/E Ratio (-13.900) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.967) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. OWLT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OWLT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MedicalNursingServices